Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

NCT03364153 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Stargardt's Macular Dystrophy

Interventions

DRUG: avacincaptad pegol
DRUG: Sham

Sponsor

Astellas Pharma Global Development, Inc.